Mednet Logo
HomeGastroenterology
Gastroenterology

Gastroenterology

Expert perspectives on IBD, liver disease, motility disorders, and GI diagnostic and therapeutic procedures.

Recent Discussions

How would you resect an 11mm sessile gastric polyp?

2
2 Answers

Mednet Member
Mednet Member
Gastroenterology · University of Arizona

I would first study the surface morphology and pit pattern. Specifically look for central depression or ulceration and signs of early cancer (such as Irregular or amorphous pit pattern). If central depression or irregular or amorphous pit pattern is present, I would consider en bloc resection with E...

How do you manage persistent rectal bleeding in the setting of rectal adenocarcinoma in a treatment-naive patient?

3
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Rutgers Robert Wood Johnson Medical School

For a locally advanced rectal adenocarcinoma in the era of TNT, treatment of the tumor with either chemoradiation or chemotherapy upfront is reasonable, and both choices are known to palliate colorectal cancers effectively. With more severe bleeding, we often consider starting with chemoradiation th...

In patients with MASLD and F2–F3 fibrosis, would you initiate Resmetirom even if they are not making active lifestyle changes?

1
3 Answers

Mednet Member
Mednet Member
Hepatology · UCLA

Yes, many patients had an underlying metabolic disorder that is difficult/impossible to address with lifestyle interventions alone and will go on to progress in their liver disease if left alone. Now with the approval of Semaglutide in August 2025 by the FDA and the approval of Resmetirom, we have t...

What are your next steps for a patient with gastritis on histology without NSAID use and H. pylori negative?

1 Answers

Mednet Member
Mednet Member
Gastroenterology · Washington University School Of Medicine Gastroenterology

Gastritis is often reported on histopathology, but without more specifics from the pathologist, it has limited clinical utility. In my experience, qualifying the pattern and extent of gastritis can provide more guidance on subsequent management. The endoscopist should assess and document the visual ...

With OpenBiome no longer in operation, what is your current approach for obtaining FMT for inpatients with acute severe/fulminant C. difficile infection unresponsive to antibiotics?

1
1 Answers

Mednet Member
Mednet Member
Gastroenterology · Mayo Clinic

Consider Rebyota by enema or flex sig, similar to what you had done with standard FMT.

In patients with MASLD, would you consider management with off-label metformin, pioglitazone (despite weight gain risk), GLP-1 RA, or simply intensify lifestyle and monitor?

3
1 Answers

Mednet Member
Mednet Member
Hepatology · UCLA

In 2025, we should be assessing if patients are developing F2-F3 fibrosis especially with the use of non-invasive assessments (FIB-4 score, transient elastography, or MRI elastography), and then offering either Semaglutide or Resmetirom for these individuals w/ F2-F3, which are the only FDA approved...

How long do you treat an isolated bacterial liver abscess which has either undergone percutaneous drainage or for which an indwelling drain is placed?

3
3 Answers

Mednet Member
Mednet Member
Infectious Disease · Cooperman Barnabas Medical Center

Until it's gone... Percutaneous drainage of liver abscesses is, in my experience, less effective than drainage of intra-abdominal abscesses, which isn't very effective. Neither type of abscess isn't, as I explain to other doctors and pts, a water balloon. Liver abscesses are more complicated than ot...

How do you choose between resmetirom and semaglutide in the treatment of MASH?

2
1 Answers

Mednet Member
Mednet Member
Hepatology · UCLA

I write a disclaimer to start, because use of resmetirom ($5,000 per month) and semaglutide ($1,600 per month) at this time cannot be used across the board with any patient with hepatic steatosis. It's important to highlight how we characterize a patient's metabolic dysfunction associated steatotic ...

After confirming the patient is not on NSAIDs, how do you approach acute ileitis on biopsies in a patient without symptoms or with only mild loose stools?

1
3 Answers

Mednet Member
Mednet Member
Gastroenterology · Northwestern Medicine

Is diarrhea inflammatory? What is her level of calprotectin? A useful biomarker to follow. Aphthous ilieitis does not have risk features for progressive Crohn’s that, at least at this time, does not require an advanced agent. You can use symptomatic agents (loperamide, cholestyramine, etc.) to asses...

How would you manage an asymptomatic patient after VCE showing small bowel Crohn's who passes the patency capsule but has retained the video capsule in the distal ileum with minimal surrounding inflammation?

2 Answers

Mednet Member
Mednet Member
Gastroenterology · Mayo Clinic

A capsule can take up to 10 days to pass in a normal situation. If you have radiographic evidence of a retained capsule and the patient is on prednisone, it might take another 2 weeks or so to get the inflammation down. Remember that the capsule should continue to get crushed and really should pass ...